<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Evidence supports an independent association between plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentrations and the risk of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent epidemiologic studies reappraised the possibility that vascular risk factors might play a role in the pathogenesis not only of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) but also of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The objective was to investigate the relations of mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, AD, and VaD with blood <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, <z:chebi fb="3" ids="37445">folate</z:chebi>, and <z:chebi fb="9" ids="17439">vitamin B-12</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: The study population consisted of 314 consecutive subjects, 228 of whom were eligible for analyses </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, serum <z:chebi fb="3" ids="37445">folate</z:chebi>, and serum <z:chebi fb="9" ids="17439">vitamin B-12</z:chebi> concentrations were measured in 55 nondemented elderly control subjects, 81 mildly cognitively impaired subjects (Clinical <z:hpo ids='HP_0000726'>Dementia</z:hpo> Rating: 0.5), and 92 demented patients prevalently in a mild disease stage and with a clinical diagnosis of AD (n = 74) or VaD (n = 18) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Subjects in the lowest <z:chebi fb="3" ids="37445">folate</z:chebi> tertile had significantly higher adjusted odds ratios (ORs) for mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (OR: 3.1; 95% CI: 1.2, 8.1) and <z:hpo ids='HP_0000726'>dementia</z:hpo> (3.8; 1.3, 11.2) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> was significantly associated with <z:hpo ids='HP_0000726'>dementia</z:hpo> (adjusted OR: 4.3; 1.3, 14.7) and AD (adjusted OR: 3.7; 1.1, 13.1) </plain></SENT>
<SENT sid="7" pm="."><plain>In subjects with a Clinical <z:hpo ids='HP_0000726'>Dementia</z:hpo> Rating of 0.5, the mean (+/- SE) Mini-Mental State Examination score was significantly lower (P &lt; 0.05) in the highest <z:chebi fb="0" ids="17230">homocysteine</z:chebi> tertile (24.5 +/- 0.5) than in the lowest tertile (26.6 +/- 0.5) </plain></SENT>
<SENT sid="8" pm="."><plain>No significant associations were found between minimum medial temporal lobe thickness or leukoaraiosis and any biochemical measure in the <z:hpo ids='HP_0000726'>dementia</z:hpo> and AD groups </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These findings suggest that relative <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency may precede AD and VaD <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> might also be an early risk factor for <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> in the elderly, but its role in <z:hpo ids='HP_0000726'>dementia</z:hpo> development must be addressed in future longitudinal studies </plain></SENT>
</text></document>